Aveo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 3.50 Cr
as on 03-07-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.27 Cr
as on 03-07-2024
- Revenue 21.73%
(FY 2021)
- Profit -6.42%
(FY 2021)
- Ebitda 868.19%
(FY 2021)
- Net Worth 48.02%
(FY 2021)
- Total Assets 4.57%
(FY 2021)
About Aveo Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹14.27 Cr.
Vinod Sharma and Arvind Sharma serve as directors at the Company.
- CIN/LLPIN
U74120MH2015PTC261024
- Company No.
261024
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aveo Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Sharma  | Director | 28-Mar-2018 | Current |
| Arvind Sharma | Director | 17-Jan-2015 | Current |
Financial Performance of Aveo Pharmaceuticals.
Aveo Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 21.73% increase. The company also saw a slight decrease in profitability, with a 6.42% decrease in profit. The company's net worth Soared by an impressive increase of 48.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aveo Pharmaceuticals?
In 2021, Aveo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aveo India Healthcare Private LimitedActive 9 months 22 daysVinod Sharma and Arvind Sharma are mutual person
- Westfin International Private LimitedActive 5 years 10 months
Vinod Sharma and Arvind Sharma are mutual person
- Aveo Film Production Private LimitedInactive For E-Filing 10 months 12 days
Vinod Sharma is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Oct 2023 | ₹2.41 Cr | Open |
Others Creation Date: 26 Sep 2023 | ₹6.11 Cr | Open |
Others Creation Date: 26 Sep 2023 | ₹4.00 Cr | Open |
How Many Employees Work at Aveo Pharmaceuticals?
Aveo Pharmaceuticals has a workforce of 20 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aveo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aveo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
